Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
02 January 2024 | Story Igno van Niekerk | Photo Igno van Niekerk
Tafadzwa Maramura
Dr Tafadzwa Maramura participated in a study on couplepreneurs and ways in which they influence their children to become better entrepreneurs.

After years of hard work, the lonely entrepreneur rode off into the sunset. No family. No one to share the lived experience with. The entrepreneurial journey can be a recipe for loneliness. However, it does not have to be, you can enjoy an entrepreneurial family that leaves a legacy.

Dr Tafadzwa C Maramura, Senior Lecturer in the Department of Public Administration and Management at the UFS participated in a study with Drs Eugine Maziriri (University of Johannesburg), Miston Mapuranga (University of Pretoria), Brighton Nyagadza (Marondera University of Agricultural Sciences) on couplepreneurs and ways in which they influence their children to become better entrepreneurs. The interinstitutional study drew on several fields of expertise and was a fresh addition to the research on access to water that Dr Maramura is doing.

Couplepreneurship is a concept that explains businesses owned and operated by married and/or cohabiting couples. According to Dr Maramura: “The development of couplepreneurship in South Africa as an emerging economy has led to increasing interest in the study of how kids are inspired and/or influenced by their parents towards starting their own and to participate in the already existing family enterprises.”

Nurturing entrepreneurial potential

Couplepreneurs are in a great position to raise kidpreneurs. Who better to listen to the heroic stories of how mom and dad started off with a big dream, growth mindsets, and steadfast commitment to building their business than their offspring? Like teaching a person how to fish rather than giving them fish, couplepreneurs do not hand their kids a business, they teach them how to run and grow a business.

Dr Maramura believes that nurturing an entrepreneurial potential is the result of “encouraging resilience, adaptability, and a willingness to embrace failure, even as a learning opportunity”. Combine this with an environment that promotes creativity, critical thinking, and problem-solving skills, and you have the recipe for a kidpreneur to become an entrepreneur. Now add more ingredients: parents who offer support, mentorship, and exposure to diverse experiences. Put it in the heated oven called business – and you have created the meal all entrepreneurs crave: Legacy.

News Archive

Nano research at the UFS opens door to smart drugs
2011-06-27

 

Prof. Lodewyk Kock, outstanding professor in our Department of Microbial, Biochemical and Food Biotechnology

Novel antifungal, anticancer and anti-malaria drugs that have been identified in the research of Prof. Lodewyk Kock, outstanding professor in the Department of Microbial, Biochemical and Food Biotechnology at our university, will be disclosed later this year at major international conferences in Asia, Europe and the USA. Prof. Kock will be the keynote speaker at these conferences. 

His presentations will be based on the department’s discovery of yeast assays linked to a new nanotechnology for medicine. The assays were recently discovered by his group and can be applied in the development of novel antifungal, anticancer and anti-malaria drugs.
 
Prof. Kock’s focused research at the university, which now also includes his novel nanotechnology for Biology, began in 1982 in collaboration with Prof. Pieter van Wyk (Centre for Microscopy). He recently collaborated with Prof. Hendrik Swart (Department of Physics).
 
Prof. Kock says the development of novel anti-malaria drugs in particular is getting attention across the world due to the high rates of morbidity and mortality caused by the disease worldwide. Approximately 225 million people are infected annually and about a million (many in Africa) die each year. “Many potential smart drugs have been identified with this research and should now be tested further,” says Kock.
  
These new drugs will be disclosed during Prof. Kock’s keynote addresses at the International Conference and Exhibition on Pharmaceutical Regulatory Affairs in Baltimore, USA, from 6 to 7 September 2011, the Medichem 2011 in Beijing, China from 9 to 11 August 2011 and the XVI Congress of European Mycologists in Greece, from 19 to 23 September 2011.

 

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept